MedTrace Logo

Patient and Physician's Satisfaction After a Long Term Treatment of Glabellar Lines With Dysport®

NCT02353897 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2020-11-05

No results posted yet for this study

Summary

This study aims to look at patient and physician satisfaction of long term Glabellar lines (GL) treatment with Dysport in a real life setting. It will also allow better understanding of what patients expect from the treatment, and the injection practices used by doctors.

Conditions

  • Glabellar Lines

Sponsors & Collaborators

Principal Investigators

  • Ipsen Medical Director · Ipsen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • Australia
  • Brazil
  • Czechia
  • Kazakhstan
  • Lebanon
  • Russia
  • Turkey (Türkiye)
  • Ukraine

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02353897 on ClinicalTrials.gov